Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network

Table 3

Thirty-one RNAs associated with prostate cancer survival.

lncRNA/miRNA	value	Better survival	mRNA	value	Better survival
lncRNA			ARSD	0.0365	High expression
FGD5-AS1	0.0368	Low expression	CNN3	0.0185	Low expression
FRG1HP	0.0383	Low expression	CRISPLD2	0.0164	High expression
GS1-124K5.12	0.0046	Low expression	CYP27A1	0.0457	High expression
LINC01082	0.0075	High expression	GAS6	0.0191	Low expression
RP11-16D22.2	0.0453	High expression	GCAT	0.0359	High expression
RP11-390F4.6	0.0462	High expression	HSPB8	0.0432	High expression
SNHG25	0.0445	Low expression	MT1X	0.0328	High expression
UBXN10-AS1	0.0075	High expression	PGM5	0.0427	High expression
			PKP3	0.0001	Low expression
miRNA			PTGDS	0.0199	High expression
hsa-miR-133a-3p	0.0176	High expression	PVRL2	0.0179	High expression
hsa-miR-133b	0.0135	High expression	RASL12	0.0251	High expression
hsa-miR-379-5p	0.0252	High expression	SEPT7	0.0341	Low expression
			SH3BGRL	0.0109	High expression
			SPOCK3	0.0022	High expression
			SSR4	0.0095	High expression
			TTLL12	0.0363	Low expression
			ULK3	0.0290	Low expression
			ZG16B	0.0042	High expression

lncRNA: long-chain noncoding RNA; miRNA: microRNA; mRNA: messenger RNA.